Increased SULT1E1 activity in HepG2 hepatocytes decreases growth hormone stimulation of STAT5b phosphorylation

Falany, 1997, Enzymology of human cytosolic sulfotransferases, FASEB J, 11, 206, 10.1096/fasebj.11.4.9068609 Falany, 1995, Bacterial expression and characterization of a cDNA for human liver estrogen sulfotransferase, J Steroid Biochem Mol Biol, 52, 529, 10.1016/0960-0760(95)00015-R Zhang, 1998, Sulfuryl transfer: the catalytic mechanism of human estrogen sulfotransferase, J Biol Chem, 273, 10888, 10.1074/jbc.273.18.10888 Kotov, 1999, Regulation of estrogen activity by sulfation in human Ishikawa endometrial adenocarcinoma cells, J Steroid Biochem Mol Biol, 68, 137, 10.1016/S0960-0760(99)00022-9 Falany, 2002, Regulation of MCF-7 breast cancer cell growth by beta-estradiol sulfation, Breast Cancer Res Treat, 74, 167, 10.1023/A:1016147004188 Li, 2007, Elevated hepatic SULT1E1 activity in mouse models of cystic fibrosis alters the regulation of estrogen responsive proteins, J Cyst Fibrosis, 6, 23, 10.1016/j.jcf.2006.05.001 Rosenberg, 2006, Mouse as a model of growth retardation in cystic fibrosis, Pediatr Res, 59, 191, 10.1203/01.pdr.0000196720.25938.be Falany, 2002, Elevation of hepatic sulphotransferase activities in mice with resistance to cystic fibrosis, Biochem J, 364, 115, 10.1042/bj3640115 Welsh, 1995 Berschneider, 1988, Altered intestinal chloride transport in cystic fibrosis, FASEB J, 2, 2625, 10.1096/fasebj.2.10.2838365 Trezise, 1991, In vivo cell-specific expression of the cystic fibrosis transmembrane conductance regulator, Nature, 353, 434, 10.1038/353434a0 Durie, 2004, Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model, Am J Pathol, 164, 1481, 10.1016/S0002-9440(10)63234-8 Boguszewski, 2007, Insulin-like growth factor-1, leptin, body composition, and clinical status interactions in children with cystic fibrosis, Hormone Res, 67, 250, 10.1159/000098480 Ozen, 2004, Relation between serum Insulin-like growth factor-I and insulin-like growth factor-binding protein-3 levels, clinical status and growth parameters in prepubertal cystic fibrosis patients, Pediatr Int, 46, 429, 10.1111/j.1442-200x.2004.01925.x Leung, 2004, Estrogen regulation of growth hormone action, Endocr Rev, 25, 693, 10.1210/er.2003-0035 Alvaro, 2007, Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver, Gastroenterol, 132, 415, 10.1053/j.gastro.2006.07.023 Rochwerger, 1994, Estrogen-dependent expression of the cystic fibrosis transmembrane regulator gene in a novel uterine epithelial cell line, J Cell Sci, 107, 2439, 10.1242/jcs.107.9.2439 Hardin, 2006, Growth hormone treatment improves growth and clinical status in prepubertal children with cystic fibrosis: results of a multicenter randomized controlled trial, J Clin Endocrinol Metab, 91, 4925, 10.1210/jc.2006-1101 Bazan, 1990, Structural design and molecular evolution of a cytokine receptor superfamily, Proc Natl Acad Sci, 87, 6934, 10.1073/pnas.87.18.6934 Argetsinger, 1993, Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase, Cell, 74, 237, 10.1016/0092-8674(93)90415-M Finidori, 2000, Regulators of growth hormone signaling, Vitam Horm, 59, 71, 10.1016/S0083-6729(00)59004-9 Herrington, 2000, The role of STAT proteins in growth hormone signaling, Oncogene, 19, 2585, 10.1038/sj.onc.1203526 Koller, 1991, Toward an animal model of cystic fibrosis: targeted interruption of exon 10 of the cystic fibrosis transmembrane regulator gene in embryonic stem cells, Proc Natl Acad Sci, 88, 10730, 10.1073/pnas.88.23.10730 Du, 2002, Aminoglycoside suppression of a premature stop mutation in a Cftr−/− mouse carrying a human CFTR-G542X transgene, J Mol Med, 80, 595, 10.1007/s00109-002-0363-1 Falany, 1997, Regulation of estrogen activity by sulfation in human MCF-7 breast cancer cells, Oncol Res, 9, 589 Ratcliff, 1993, Production of a severe cystic fibrosis mutation in mice by gene targeting, Nat Genet, 4, 35, 10.1038/ng0593-35 Christoforidis, 2005, Growth hormone/insulin-like growth factor-1 axis during puberty, Pediatr Endocrinol Rev, 3, 5 Davey, 2001, STAT5b is required for GH-induced liver IGF-I gene expression, Endocrinology, 142, 3836, 10.1210/en.142.9.3836 Holloway, 2007, Loss of sexually dimorphic liver gene expression upon hepatocyte-specific deletion of Stat5a–Stat5b locus, Endocrinology, 148, 1977, 10.1210/en.2006-1419 Phung-Koskas, 2005, STAT5B-mediated growth hormone signaling is organized by highly dynamic microtubules in hepatic cells, J Biol Chem, 280, 1123, 10.1074/jbc.M409918200 Carter-Su, 1996, Signalling pathway of GH, Endocr J, 43, S65, 10.1507/endocrj.43.Suppl_S65 Waxman, 2006, Growth hormone regulation of sex-dependent liver gene expression, Mol Endocrinol, 20, 2613, 10.1210/me.2006-0007 Deroo, 2006, Estrogen receptors and human disease, J Clin Invest, 116, 561, 10.1172/JCI27987 Fawell, 1990, Inhibition of estrogen receptor-DNA binding by the “pure” antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization, Proc Natl Acad Sci, 87, 6883, 10.1073/pnas.87.17.6883 Wakeling, 1991, A potent specific pure antiestrogen with clinical potential, Cancer Res, 51, 3867 Wakeling, 1995, Tissue-specific actions of antioestrogens, Mutat Res, 333, 45, 10.1016/0027-5107(95)00130-1 Byard, 1994, The adolescent growth spurt in children with cystic fibrosis, Ann Human Biol, 21, 229, 10.1080/03014469400003242 Arumugam, 1998, Serum leptin and IGF-I levels in cystic fibrosis, Endocr Res, 24, 247, 10.1080/07435809809135532 Morison, 1997, Height and weight in cystic fibrosis: a cross sectional study. UK Cystic Fibrosis Survey Management Committee, Arch Dis Child, 77, 497, 10.1136/adc.77.6.497 Park, 2006, Signaling cross-talk between hepatocyte nuclear factor 4alpha and growth-hormone-activated STAT5b, Biochem J, 397, 159, 10.1042/BJ20060332 Venken, 2005, Growth without growth hormone receptor: estradiol is a major growth hormone-independent regulator of hepatic IGF-I synthesis, J Bone Miner Res, 20, 2138, 10.1359/JBMR.050811 Leung, 2007, Regulation of growth hormone signaling by selective estrogen receptor modulators occurs through suppression of protein tyrosine phosphatases, Endocrinology, 148, 2417, 10.1210/en.2006-1305 Chen, 1991, Further characterization of insulin-like-growth factor binding proteins in rat osteoblast-like cell cultures: modulation by 17 beta-estradiol and human growth hormone, Endocrinology, 128, 2489, 10.1210/endo-128-5-2489 Hsieh, 2007, G protein-coupled receptor 30-dependent protein kinase A pathway is critical in nongenomic efects of estrogen in attenuating liver injury after trauma-hemorrhage, AM J Pathol, 170, 1210, 10.2353/ajpath.2007.060883 Rae, 2005, What does an orphan G-protein-coupled receptor have to do with estrogen?, Breast Cancer Res, 7, 243, 10.1186/bcr1330 Bjornstrom, 2002, Signal transducers and activators of transcription as downstream targets of nongenomic estrogen receptor actions, Mol Endocrinol, 16, 2202, 10.1210/me.2002-0072 Cook, 2000, The adult growth hormone deficiency syndrome, Adv Intern Med, 45, 297 Cook, 2004, Growth hormone and estrogen: a clinician’s approach, J Pediatr Endocrinol Metab, 17, 1273 Hardin, 2005, Growth hormone improves bone mineral content in children with cystic fibrosis, J Pediatr Endocrinol Metab, 18, 589, 10.1515/JPEM.2005.18.6.589 Hardin, 2006, Growth hormone treatment improves growth and clinical status in prepubertal children with cystic fibrosis: results of a multicenter randomized controlled trial, J Clin Endocrinol Metab, 91, 4925, 10.1210/jc.2006-1101 Colombo, 1998, Liver and biliary problems in cystic fibrosis, Semin Liver Dis, 18, 227, 10.1055/s-2007-1007159